Success Stories: EB-1A Petition Approved for Postdoctoral Associate in New York in the Field of Biotechnology
Client’s Testimonial:
“I am very impressed with your service in every aspect, including answering every question on time. You guys are very systematic and did a wonderful job. I am satisfied with your service, not only this time, but also during my EB2 filing. I am recommending you to all my friends who are willing to file their green card.”
On January 7th, 2016, we received another EB1-A (Alien of Extraordinary Ability) approval for a Postdoctoral Associate in the Field of Biotechnology (Approval Notice).
General Field: Biotechnology
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: New York
Approval Notice Date: January 7th, 2016
Processing Time: 45 days (Premium Processing requested)
Case Summary:
Some time ago, North America Immigration Law Group filed an EB-1A (Alien of Extraordinary Ability) petition for a postdoctoral associate from India. Our client requested Premium Processing; however, the USCIS took over 45 days to approve his case. This was because of the Notice of Intent to Deny (NOID) that they issued. Fortunately, our team is highly skilled at addressing these notices, and we worked assiduously to prove to the USCIS that our client’s petition deserved approval. The USCIS agreed with our presentation and our client is now on his way to getting a green card.
At the time of filing, our client’s professional record included 66 citations and seven published papers. He had also judged 23 papers for numerous scientific journals. In addition to carefully accounting for this information, we also presented several recommendation letters contributed by experts in our client’s field of biotechnology. One of the letters stated, “[Client] has dedicated his intelligence and expertise to better understanding the mechanism of the pathogenesis of disease and its prevention. It is thus clear that the research he conducts is of national significance.” This, along with other relevant evidence that we included in the EB1A petition, asserted the significance of our client’s research to the United States. Our efforts established the many ways in which our client’s work has influenced medical science, particularly his area of study that focuses on molecular mechanisms in glaucoma and retinal neurodegeneration.
We extend our congratulations to this postdoctoral associate, and wish him all the best in his continued research.

